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Abstract: 
Objective: of our study was to evaluate the incidence of acute fibrillation developing in the context of acute 
myocardial infarction population. Methodology: This cross sectional study was carried out in department 
Cardiology Nishtar Hospital, Multan under supervision of senior cardiologists. Patients who were presented with 
acute myocardial infarction selected for study, duration April 2018 to February 2019. Data was entered and 
analyzed by using SPSS software, mean and SD representation was done for continuous data like age and 
frequency (percentages %) representation were done for categorical variables like gender, hypertension, DM, onset 
of old AF and new AF. chi square test was applied to see association between variables. P value less than or equal 
to 0.05 was considered as significant.  Results: A total of 214 patients were enrolled in this study. There was 
association between new onset of AF and age (p=0.000). Old AF found in 7.9% (n=17) in patients. The main 
outcome of this study was new outset AF, in our study, it was found in 18.7% (n=40) patients. Conclusion: New 
onset of atrial fibrillation is a common type of Arrhythmia which is highly associated with ST segment elevation 
mayocardial infarction or acute mayocardial infarction. 
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Introduction: 
Most common arrhythmia of acute ST segment elevation is atrial fibrillation; it is also frequent in acute coronary 
syndrome1. It is reported in previous literature that incidence of atrial fibrillation in AMI increased 13.3% in last 
few years. In setting G of AMI atrial fibrillation have bad impact with slow clinical outcomes and poor prognosis2. 
Outcomes of its treatment and prognosis can increased with better perfusion strategies which include use of 
angiotension enzyme inhibitors and PCI, statins, modern antithrombotic treatment and angiotensionreceptors 
blockers in acute myocardial infarction patients3,4. 
Along with advance management of AMI there is a need of treatment of its new acute phase attacks, it could be 
with lifestyle modifications or dietary changes5. Predictors of new onset should inhibit. In 12% of AF cases can 
be encountered with thrombolytic agents or PCI. About 4.5% cases which are treated with primary PCI have 
arrhythmia in pre hospital time6. Incidence of AF found to be doubled when observed with long term implantable 
event loop in comparison with ECG monitoring7. Patients of AF with acute phase of AMI faces more badly 
condition when they are in their older age, hemodynamicaly unstable and increase in comorbidities8. 
In a previous trial which was conducted on four thrombolytic regimens it was reported that patients of AF were 
mostly female of older age having high heart rate and low blood pressure, some other risk factors include previous 
history of myocardial infarction, hypertension9, compromised heart, low ejection fraction, coronary artery disease 
and triple vessel disease. Incidence of atrial fibrillation can be treated with beta blockers and aspirin, its advance 
management include digoxin, anti arrhythmics and warfarin10. Local evidences of AF in acute MI are much 
deficient, we decided to conduct this study, which will provide basis for fut.ure research on this very import subject 
 
Methodology 
This cross sectional study was carried out department Cardiology Nishtar Hospital, Multan under supervision of 
senior cardiologists Patients who were presented with acute myocardial infarction selected for study, duration 
April 2018 to February 2019, age more than 18 years and raised troponin level were included in the study. 
Sampling technique used for this study was non probability consecutive. Sample size was taken after using CI of 
95%, power 80% and onset of new atrial fibrillation of (p) 8%. Patients were also evaluated for prolonged ischemic 
signs and ST segment depression or elevation on ECG. Patients who were send to another institution for any 
procedure which is more than 24 hours prolonged, who did not give consent for inclusion in the study were 
excluded from the study. Patients detailed history for socioeconomic status, previous illness or comorbid disease 
and previous hospital admission and treatment was obtained. Blood samples were drawn taking all aseptic 
measures. Our main outcome variable is new onset of AF in time duration of AMI admission in hospital. It was 
considered as AF when it was recorded on 12 leads ECG for more than 30 seconds. Patient’s biomarker, detailed 
history points, and new onset of AF were recorded. 
Data was entered and analyzed by using SPSS software, mean and SD representation was done for continuous data 
like age and frequency (percentages %) representation were done for categorical variables like gender, 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal DOI: 10.7176/JMPB 
Vol.52, 2019 
 
79 
hypertension, DM, onset of old AF and new AF. chi square test was applied to see association between variables. 
P value less than or equal to 0.05 was considered as significant.  
Results: 
  A total of 214 patients were enrolled in this study, both genders. Gender distribution showed there were 
57.9% (n=124) males and 42.1% (n=90) females. The mean age of the patients was 63.24±3.03 years. 
Hypertension noted in 70.1% (n=150) patients. While, DM was found in 76.2% (n=163) patients. There was 
association between new outset AF and age (p=0.000). Old AF found in 7.9% (n=17) in patients. The main 
outcome of this study was new outset AF, in our study, it was found in 18.7% (n=40) patients.  (Table. 1-3). 
 
Table-1: Demographic characteristics 
Variable Frequency Percentage 
Gender M=124, F=90 M=57.9%, F=42.1% 
Hypertension 150 70.1 
DM 163 76.2 
Age (years) 63.24±3.03 
 
Table-2: Onset of old and new Atrial Fibrilation 
Variable Frequency Percentage % 
Old AF 17 7.9 % 
New outset AF 40 18.7 % 
 
Table-3: Association of new outset AF with effect modifiers 
Effect Modifiers New outset AF Total P-value 
Yes No 
Gender Male 20 104 124 0.259 
Female 
20 70 90 
Total 40 174 214 
Stratified Age 38-50 Years 4 94 98 0.000 
51-82 Years 36 80 116 
Total 40 174 214 
Hypertension 
Yes 
32 118 150 0.129 
No 
8 56 64 
Total 40 174 214 
DM Yes  32 131 163 
0.528 
No 8 43 51 
Total 40 174 214 
Old AF Yes 5 12 17 
0.237 
No 35 162 197 
 Total 40 174 214 
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Discussion: 
 It was seen in previous literature that onset of new AF is associated with reflex automatic heart rate control 
especially in those patients who were diagnosed with acute myocardial infarction. In our main outcome of our 
study was new outset AF and it was found in 18.7% of patients. This may b due to hemodynamic changes which 
are observed in most of STEMI patients.  
In a study conducted by Lehto M et al11 reported 12% atrial fibrillation and among them 7.2% patients were those 
who develop new onset after acute mayocardial infarction. Mostly AF was observed after AMI which leads to 
heart failure and may be death.  This study is comparable with our study but onset of new AF was less than ours. 
This incidence may be varying from area to area of living style. 
In another study conducted by Køber L et al12 on this topic in 2006 and reported 37% incidence of current AF in 
previous AMI patients which is a high ratio as compared to almost all previous studies conducted on this topic. In 
another study by Jons C et al13 reported that incidence of new onset of AF is after MI is high about 16% was 
reported, he also claims that this incidence rate is higher in first two month after MI and then decreases with time. 
Cerit L14 et al conducted a study in 2017 and reported that AF is highly associated with AMI and in cases of MI 
arrhythmias are common, among them AF is most common type of arrhythmia. In a study conducted by Lopes 
RD et al15 and reported incidence of new onset of AF after MI 6.3%. It is not a too much high percentage and also 
similar ratio was reported. This study is also comparable with our study. 
In our study we observed that incidence of new onset of AF in MI patients is also associated with age, with passage 
of time risk of this incidence also increases. In a study conducted by Vukmirović M et al16 reported 6% incidence 
of AF after AMI and also reported that new onset of AF is associated with age. Arrhythmias are common in older 
age. Pedersen OD et17 al also reported that atrial flutter and fibrillation is common in after AMI in older ages. 
In a study conducted by Pizzetti F et18 al reported 7.8% incidence of AF after AMI and reported that AMI patients 
shows worse prognosis after AF. Anoter study by Crenshaw BS et al19 also reported similar findings. This study 
is comparable with our study. In other studies similar findings were reported and it is a calibrated fact that new 
onset of AF after AMI is common arrhythmia and found to be fatal and high incidence of mortality associated with 
it20.  
 
Conclusion: 
New onset of atrial fibrillation is a common type of Arrhythmia which is highly associated with ST segment 
elevation mayocardial infarction or acute mayocardial infarction. 
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